Search research articles
Contact Us
Filters
Showing results (71-80 of 121) with videos related to
Page
of 13
Sort By:
Cancer Treatment Reports
|
January 1, 1987
1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society
H E Wander, W E Berdel, K Bremer, et al.
Langenbecks Archiv Fur Chirurgie
|
January 1, 1988
[When are current methods of chemotherapy of gastrointestinal tumors of reliable value?]
U Fink, H O Klein, P Preusser, et al.
Onkologie
|
October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'
W Queisser, H Flechtner, M E Heim, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma
H Wagner, K Possinger, K Bremer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 11, 1982
[Programmed after care of breast cancer. Results of a follow-up model after 2 years later]
W Queisser, H Lochbühler, P Filzmayer, et al.
Developments in Biological Standardization
|
April 13, 1977
Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary results
A C Mayr, H J Senn, W M Gallmeier, et al.
Klinische Wochenschrift
|
May 15, 1972
[Comparison of cytological and cytochemical classification in 47 cases of acute leukaemia]
W Queisser, M Dietrich, J Finke, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results
P Schlag, W Schreml, W Gaus, et al.
Blut
|
January 1, 1977
In vivo study of platelet kinetics by 75Se-methionine in different haematological disorders
U Müller, J Kulinna, J Lüber, et al.
Onkologie
|
February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]
S Verhees, H Flechtner, W Queisser, et al.
Page
of 13
Search research articles
Search
Showing results (71-80 of 121) with videos related to
Sort By:
Page
of 13
Cancer Treatment Reports
|
January 1, 1987
1,2,4-Triglycidylurazol in advanced breast cancer: a trial of the phase II study group of the Association of Medical Oncology, German Cancer Society
H E Wander, W E Berdel, K Bremer, et al.
Langenbecks Archiv Fur Chirurgie
|
January 1, 1988
[When are current methods of chemotherapy of gastrointestinal tumors of reliable value?]
U Fink, H O Klein, P Preusser, et al.
Onkologie
|
October 1, 1989
Dose escalation and split course of 4-epidoxorubicin in combination chemotherapy (FEM II) of advanced gastric carcinoma. A phase-II trail of the 'Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)'
W Queisser, H Flechtner, M E Heim, et al.
Cancer Treatment Reports
|
February 1, 1987
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma
H Wagner, K Possinger, K Bremer, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 11, 1982
[Programmed after care of breast cancer. Results of a follow-up model after 2 years later]
W Queisser, H Lochbühler, P Filzmayer, et al.
Developments in Biological Standardization
|
April 13, 1977
Randomized trial in advanced breast cancer using combination chemotherapy with or without C. parvum; preliminary results
A C Mayr, H J Senn, W M Gallmeier, et al.
Klinische Wochenschrift
|
May 15, 1972
[Comparison of cytological and cytochemical classification in 47 cases of acute leukaemia]
W Queisser, M Dietrich, J Finke, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1982
Adjuvant 5-fluorouracil and BCNU chemotherapy in gastric cancer: 3-year results
P Schlag, W Schreml, W Gaus, et al.
Blut
|
January 1, 1977
In vivo study of platelet kinetics by 75Se-methionine in different haematological disorders
U Müller, J Kulinna, J Lüber, et al.
Onkologie
|
February 1, 1990
[Treatment of advanced pancreatic cancer with 5-fluorouracil, 4-epidoxorubicin and mitomycin C (FEM II). From the Chemotherapy of Gastrointestinal Tumors Group]
S Verhees, H Flechtner, W Queisser, et al.
Page
of 13